Key biosensor components of Archer’s lab-on-a-chip device miniaturised to nanosize chip formats, a requirement for successful biochip development.
• Archer team grows, introducing world-class expertise and capabilities spanning
nanotechnology, advanced materials, and molecular biology.
• The Company is utilising over $150 million of sophisticated chip building facilities
in Australia to manufacture its graphene-based biochip technology.
• Lab-on-a-chip devices form part of the multibillion dollar deep-tech economy,
catalysed by the global need for point of care medical diagnostics and testing†,‡.
• Archer team grows, introducing world-class expertise and capabilities spanning
nanotechnology, advanced materials, and molecular biology.
• The Company is utilising over $150 million of sophisticated chip building facilities
in Australia to manufacture its graphene-based biochip technology.
• Lab-on-a-chip devices form part of the multibillion dollar deep-tech economy,
catalysed by the global need for point of care medical diagnostics and testing†,‡.